Martin, T.G.; Corzo, K.; Chiron, M.; van de Velde, H.; Abbadessa, G.; Campana, F.; Solanki, M.; Meng, R.; Lee, H.; Wiederschain, D.;
et al. Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab. Cells 2019, 8, 1522.
https://doi.org/10.3390/cells8121522
AMA Style
Martin TG, Corzo K, Chiron M, van de Velde H, Abbadessa G, Campana F, Solanki M, Meng R, Lee H, Wiederschain D,
et al. Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab. Cells. 2019; 8(12):1522.
https://doi.org/10.3390/cells8121522
Chicago/Turabian Style
Martin, Thomas G., Kathryn Corzo, Marielle Chiron, Helgi van de Velde, Giovanni Abbadessa, Frank Campana, Malini Solanki, Robin Meng, Helen Lee, Dmitri Wiederschain,
and et al. 2019. "Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab" Cells 8, no. 12: 1522.
https://doi.org/10.3390/cells8121522
APA Style
Martin, T. G., Corzo, K., Chiron, M., van de Velde, H., Abbadessa, G., Campana, F., Solanki, M., Meng, R., Lee, H., Wiederschain, D., Zhu, C., Rak, A., & Anderson, K. C.
(2019). Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab. Cells, 8(12), 1522.
https://doi.org/10.3390/cells8121522